Melanie Märklin

31PUBLICATIONS
141CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Feb 19, 2026
Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3).

Sylwia A Stefańczyk, Xenija Kaiser, Ilona Hagelstein

|Oct 03, 2025
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia.

Melissa Zwick, Bastian Zinkel, Corinna Spohr

|Jul 13, 2024
Expression and Prognostic Value of a Novel B7-H3 (CD276) Antibody in Acute Myeloid Leukemia.

Sylwia A Stefańczyk, Clara Hayn, Jonas Heitmann

|Apr 18, 2024
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody.

Sylwia A Stefańczyk, Ilona Hagelstein, Martina S Lutz

|Apr 13, 2024
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome.

Anna Seller, Christian M Tegeler, Jonas Mauermann

Pageof 6